Cargando…
High Level of Legumain Was Correlated With Worse Prognosis and Peritoneal Metastasis in Gastric Cancer Patients
Background: Accumulating evidence has demonstrated that legumain (LGMN) is abnormally expressed in several malignancies and functions as an oncogene. However, the association between LGMN and gastric cancer (GC) has not yet been fully elucidated. In this study, we performed a comprehensive analysis...
Autores principales: | Wang, Yan, Zhang, Shilong, Wang, Haiwei, Cui, Yuehong, Wang, Zhiming, Cheng, Xi, Li, Wei, Hou, Jun, Ji, Yuan, Liu, Tianshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378441/ https://www.ncbi.nlm.nih.gov/pubmed/32766126 http://dx.doi.org/10.3389/fonc.2020.00966 |
Ejemplares similares
-
Expression of Legumain Correlates with Prognosis and Metastasis in Gastric Carcinoma
por: Guo, Pengtao, et al.
Publicado: (2013) -
MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain
por: Zhang, Yi, et al.
Publicado: (2016) -
Editorial: Peritoneal metastasis of gastric cancer
por: Wang, Shuyi, et al.
Publicado: (2023) -
CT characteristics for predicting prognosis of gastric cancer with synchronous peritoneal metastasis
por: Li, Jiazheng, et al.
Publicado: (2023) -
NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer
por: Cui, Yuehong, et al.
Publicado: (2021)